The comment I was replying to:
>Often times, you’re looking at 10-100x the cost for “statistically significant” uplift in efficacy. What happened to value-based medicine?
If that's the case, sounds like the extra cost is worth it.
The comment I was replying to:
>Often times, you’re looking at 10-100x the cost for “statistically significant” uplift in efficacy. What happened to value-based medicine?
If that's the case, sounds like the extra cost is worth it.